Accessing the China market using a Localization Strategy: Opportunities and Challenges

Accessing the China market using a Localization Strategy: Opportunities and Challenges

Tuesday, April 16, 2024 2:40 PM to 3:00 PM · 20 min. (US/Pacific)
Biosimilars Market Access
Presentation
Room 7b

Information

• Exploring how China has emerged as a cost-effective biomanufacturing hub for both the rapidly growing Chinese market and the rest of the world

• Examining new the new guidelines set by the Center for Drug Evaluation (CDE) that clarify the requirements for "localization" and encourage global biopharma companies to adopt a "China for China" manufacturing strategy

• How can global biopharma companies leverage this trend, and what challenges and pitfalls should they avoid?

• How can a reliable CDMO assist in navigating China's complex regulatory landscape and expediting the commercialization process?


Altruist Bio814Altruist Biologics is a leading CDMO company in China focusing on the development and commercial manufacturing of antibodies, fusion proteins, ADCs, gene and cell therapies and other drugs. Altruist Biologics is committed to "Helping customers develop affordable and high-quality biopharmaceuticals to patients across the world". The company has established an experienced international talent team, and helped our clients commercialization of 8 products for more than 1 million patients. Altruist Biologics currently has the total capacity of 60,000 liters in Suzhou, meeting the GMP requirements of NMPA, FDA and EMA. Altruist Biologics also has 172,000L of capacity under construction at Hangzhou, of which 4* 20,000L bioreactors have been completed. Altruist Biologics is committed to providing high-quality, industry-leading one-stop services, and assisting our clients to deliver innovative medicines to benefit more patients. "Perseverance for Altruism, Ingenuity for Sustainability" is our commitment to achieve a win-win partnership. Our mission is to helping customers develop affordable and high-quality biopharmaceuticals to patients across the world.

Log in